Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,744) Arrow Down
Filter Results: (2,744) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,754)
    • People  (17)
    • News  (2,102)
    • Research  (2,744)
    • Events  (3)
    • Multimedia  (223)
  • Faculty Publications  (2,098)

Show Results For

  • All HBS Web  (5,754)
    • People  (17)
    • News  (2,102)
    • Research  (2,744)
    • Events  (3)
    • Multimedia  (223)
  • Faculty Publications  (2,098)
← Page 123 of 2,744 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 15 Aug 2017
  • First Look

First Look at New Research and Ideas, August 15, 2017

2017 Washington, DC: American Public Health Association Public Health Preparedness: Case Studies in Policy and Management By: Howitt, Arnold M., Dutch Leonard, and David W. Giles, eds. Abstract—This book... View Details
Keywords: Sean Silverthorne
  • 18 Aug 2009
  • First Look

First Look: August 18

students in the EC course, "Competing Through Business Models." Purchase this course overview : http://cb.hbsp.harvard.edu/cb/product/710409-PDF-ENG Dartmouth-Hitchcock Medical Center: Spine Care Harvard Business School Case... View Details
Keywords: Martha Lagace
  • 2025
  • Working Paper

Prozac—Controversial Blockbuster: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes the development of Prozac, a blockbuster drug that transformed the treatment of depression – and became a cultural phenomenon in the United States. Specifically, we chronicle the: 1) prior treatments for depression and the research that... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Citation
SSRN
Read Now
Related
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Prozac—Controversial Blockbuster: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-135, July 2020. (Revised January 2025.)
  • 2025
  • Working Paper

Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Citation
SSRN
Read Now
Related
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-005, July 2019. (Revised January 2025.)
  • 30 Apr 2013
  • First Look

First Look: April 30

longitudinal data from 68 multi-method case studies of organizational change initiatives conducted at the National Health Service in the United Kingdom support these predictions and advance a relational view of organizational change in... View Details
Keywords: Sean Silverthorne
  • September 2009 (Revised September 2010)
  • Case

Avid Radiopharmaceuticals and Lighthouse Capital Partners

By: Matthew Rhodes-Kropf and Ann Leamon
In fall 2008, a venture lender must decide whether to make a loan to Avid, a small but promising venture-backed life sciences firm. In reviewing her proposal, Cristy Barnes considers the company's characteristics and how they differ from a typical investment. At the... View Details
Keywords: Business Startups; Decision Choices and Conditions; Financial Crisis; Venture Capital; Private Equity; Financing and Loans; Investment; Health Industry; Health Industry
Citation
Educators
Purchase
Related
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals and Lighthouse Capital Partners." Harvard Business School Case 810-054, September 2009. (Revised September 2010.)
  • 13 Apr 2015
  • Research & Ideas

3 Ways Firms Can Profit From Environmental Investments

strategy has less than a 50 percent probability of panning out. "What sustainability analysis does is to really make [executives] stop and think," she says. "'Will consumers start to care about this? Will we face new regulatory pressures?... View Details
Keywords: by Carmen Nobel; Energy; Utilities
  • 14 Jun 2016
  • First Look

June 14, 2016

challenging work environments. This article focuses on two such contexts—health care and education. The authors theorize differences in psychological safety based on work type, hierarchical status, and leadership effectiveness. Consistent... View Details
Keywords: Sean Silverthorne
  • 28 Aug 2017
  • Research & Ideas

Should Industry Competitors Cooperate More to Solve World Problems?

example here. More business leaders in the health care sector recognize that industry actors that engage in egregious pricing of drugs bring all kinds of problems to the whole industry. Silverthorne: You... View Details
Keywords: by Sean Silverthorne; Financial Services; Manufacturing; Agriculture & Agribusiness; Mining
  • 01 May 2020
  • In Practice

COVID-19’s Hard Lessons Might Prepare Business for Climate Change

can deliver the safest perceived service environment, in the face of ongoing public health threats from COVID-19 and from the next pandemic. Sustaining their business viability post-COVID will demand more resources and a higher carbon... View Details
Keywords: by Danielle Kost
  • 29 May 2012
  • First Look

First Look: May 29

of strong ties to resistors accruing to the change agent are weaker and may yet turn into liabilities that reduce the likelihood of change adoption. Analyses of longitudinal data from 68 multi-method case studies of organizational change initiatives conducted at the... View Details
Keywords: Sean Silverthorne
  • 18 Feb 2009
  • First Look

First Look: February 18, 2009

School Case 809-009 To help her finance her aggressive expansion plans, Genevieve Thiers plans to raise venture capital for the first time. She has spent the last six long years building Sittercity into the nation's leading babysitting... View Details
Keywords: Martha Lagace
  • December 2010
  • Teaching Note

Roche's Acquisition of Genentech (TN)

By: Bo Becker and Carliss Y. Baldwin
Teaching Note for 210-040. View Details
Keywords: Mergers and Acquisitions; Stock Shares; Opportunities; Strategy; Organizational Culture; Value; Negotiation Tactics; Health Industry; Health Industry
Citation
Purchase
Related
Becker, Bo, and Carliss Y. Baldwin. "Roche's Acquisition of Genentech (TN)." Harvard Business School Teaching Note 211-039, December 2010.
  • 14 May 2013
  • First Look

First Look: May 14

P/E industries, which have a negative valuation change in the year after the investment. 2006 New England Journal of Medicine Leading Clinicians and Clinicians Leading By: Bohmer, Richard M.J. Abstract—More effective models of care... View Details
Keywords: Sean Silverthorne
  • 07 Aug 2007
  • First Look

First Look: August 7, 2007

providing information for students on CWA's history, the nature of Section 363 auctions, and the bidders who were involved in the process. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=908004 Connectivity in View Details
Keywords: Martha Lagace
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

to customize therapy for individuals. However, adoption of this approach has progressed slowly and unevenly because the trial-and-error treatment model still governs how the health care system develops,... View Details
Keywords: Martha Lagace
  • January 2002
  • Case

Price-Fixing Vignettes

By: Guhan Subramanian and Michelle Kalka
This case escribes the antitrust prosecutions in the United States and abroad of the international bulk vitamins cartel. Both the civil and criminal fines were historically high, and it was the first time the United States prosecuted foreign nationals for U.S. criminal... View Details
Keywords: Price; Lawsuits and Litigation; Governance Compliance; Auctions; Laws and Statutes; Monopoly; Globalized Markets and Industries; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Subramanian, Guhan, and Michelle Kalka. "Price-Fixing Vignettes." Harvard Business School Case 902-068, January 2002.
  • March 2021 (Revised May 2021)
  • Supplement

Blue Meridian Partners (B): Pivoting in a Crisis

By: V. Kasturi Rangan
The (B) case situated in 2020 describes the many quick decisions taken by the fund in response to the COVID-19 pandemic and the calls for social justice, and raises the question of whether and how these decisions are aligned with the long range strategy of the fund. View Details
Keywords: Venture Philanthropy; COVID-19; Philanthropy and Charitable Giving; Venture Capital; Social Issues; Health Pandemics; Decisions; Strategy
Citation
Purchase
Related
Rangan, V. Kasturi. "Blue Meridian Partners (B): Pivoting in a Crisis." Harvard Business School Supplement 521-091, March 2021. (Revised May 2021.)
  • 15 Sep 2008
  • Research & Ideas

The Coming Transformation of Social Enterprise

sense when the for-profit and nonprofit parts are tightly linked by a common purpose or platform. For example, in health care several very successful social entrepreneurs have created a hybrid model where... View Details
Keywords: by Roger Thompson
  • January 2021 (Revised June 2021)
  • Case

Hester Pharmaceuticals (A): A Pricing Dilemma

By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Citation
Educators
Purchase
Related
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
  • ←
  • 123
  • 124
  • …
  • 137
  • 138
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.